Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-021630
Filing Date
2014-05-29
Accepted
2014-05-29 16:40:36
Documents
1
Period of Report
2014-05-28

Document Format Files

Seq Description Document Type Size
1 LYNCH F4 5-28-14 rrd410467.html 4  
1 LYNCH F4 5-28-14 rrd410467.xml 4 3959
  Complete submission text file 0001181431-14-021630.txt   5352
Mailing Address
Business Address
LYNCH DANIEL (Reporting) CIK: 0001177082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36072 | Film No.: 14876554

Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Issuer) CIK: 0001385228 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations